Esophageal Cancer Research and TreatmentGastric Cancer Management and OutcomesPancreatic and Hepatic Oncology ResearchCancer, Stress, Anesthesia, and Immune ResponseCancer Immunotherapy and Biomarkers
Publications
119
Citations
1,076
Est. group size
~2
Recurring co-author estimate
Active years
22
Publishing since 2005
Publication cadence
Publications per year over the last 10 years — averaging 7.8/year recently
Recent publications
- Abstract 295: Antitumor effect of a new pyruvate kinase M2 (PKM2) inhibitor Acyclovir in experimental esophageal adenocarcinoma.
Cancer Research · 2026
- Abstract 401: Targeting Hsp90β potentiates nab-paclitaxel-based chemotherapy response in pancreatic cancer models.
Cancer Research · 2026
- Synergistic Disruption of Survival and Metastatic Potential in Esophageal Adenocarcinoma Cells Through Combined Inhibition of HIF1α and CD73
Preprints.org · 2025
- Abstract 3035: Effects of novel isoform selective HSP90 beta inhibitors alone and in combinations against experimental esophageal adenocarcinoma
Cancer Research · 2025
- Abstract 3080: PKM2 inhibition overcomes lapatinib resistance in HER2 overexpressing esophageal adenocarcinoma
Cancer Research · 2025
- Transcriptomic profiling of laser-capture microdissected FFPE esophageal tissues identifies key drivers of esophageal adenocarcinoma
SSRN Electronic Journal · 2025
- Expanding Horizons in Cholangiocarcinoma: Emerging Targets Beyond FGFR2 and IDH1
International Journal of Molecular Sciences · 2025
- Abstract 5640: The KRASG12Dinhibitor MRTX1133 demonstrates significant antitumor activity and enhances nanoparticle-paclitaxel chemotherapy outcomes in pancreatic cancer
Cancer Research · 2025
- Potent antitumor activity of the KRAS <sup>G12D</sup> inhibitor MRTX1133 in pancreatic cancer: Augmenting the nanoparticle-paclitaxel chemotherapy response.
Journal of Clinical Oncology · 2025
- Abstract 555: Role of TRIM31 in the pathogenesis of esophageal adenocarcinoma
Cancer Research · 2024
- TRIM31: A Protein With an Oncogenic Role in Esophageal Adenocarcinoma
Proceedings of IMPRS · 2024
- Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma
Cancers · 2024
- Abstract 3960: Therapeutic targeting of HIF-1 alpha induced CD73 expression in experimental esophageal adenocarcinoma
Cancer Research · 2023
- Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety
Biomedicines · 2023
- Supplementary Figure 1 from GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer
2023
Publishes in
- Cancer Research×24
- PMC×3
- Experimental and Molecular Therapeutics×3
- BMC Cancer×2
- Scientific Reports×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile